CG Oncology (CGON) Capital Expenditures (2024 - 2026)
CG Oncology posted quarterly Capital Expenditures of $304000.0 for Q1 2026, up 1800.0% year-on-year from $16000.0 in Q1 2025, and up 4242.86% on a QoQ basis from $7000.0 in Q4 2025.
CG Oncology (CGON) has 3 years of Capital Expenditures data on file, last reported at $304000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 1800.0% year-over-year to $304000.0; the trailing twelve-month figure through Mar 2026 stood at $422000.0 (up 77.31% YoY), and the FY2025 full-year result was $134000.0, down 42.74% from the prior year.
- Capital Expenditures for Q1 2026 stood at $304000.0, up from $7000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $304000.0 in Q1 2026 and bottomed at -$1000.0 in Q3 2024.
- The 3-year median for Capital Expenditures is $14000.0 (2024), against an average of $74666.7.
- Peak annual rise in Capital Expenditures reached 9800.0% in 2025, while the deepest fall reached 96.65% in 2025.
- A 3-year view of Capital Expenditures shows it stood at $209000.0 in 2024, then slumped by 96.65% to $7000.0 in 2025, then surged by 4242.86% to $304000.0 in 2026.
- The last three Capital Expenditures figures came in at $304000.0 (Q1 2026), $7000.0 (Q4 2025), and $97000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | CG Oncology | 5.01 Bn | 5.01 Bn | -1.88 Mn | 304,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 304,000.00 |
| Mar 31, 2026 | 304,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 209,000.00 |
| Dec 31, 2024 | 209,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Mar 31, 2024 | 12,000.00 |